System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
J Transl Med. 2022 Oct 4;20(1):452. doi: 10.1186/s12967-022-03630-1.
J Transl Med. 2022.
PMID: 36195876
Free PMC article.